526 related articles for article (PubMed ID: 34054510)
21. Beta-caryophyllene is a dietary cannabinoid.
Gertsch J; Leonti M; Raduner S; Racz I; Chen JZ; Xie XQ; Altmann KH; Karsak M; Zimmer A
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9099-104. PubMed ID: 18574142
[TBL] [Abstract][Full Text] [Related]
22. β-caryophyllene, a cannabinoid receptor 2 agonist, decreases the motivational salience and conditioning place preference for palatable food in female mice.
Dos Santos Barbosa LA; Dutra RC; Moreira ELG; de Carvalho CR
Addict Biol; 2023 Jan; 28(1):e13249. PubMed ID: 36577722
[TBL] [Abstract][Full Text] [Related]
23. Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders.
Ricardi C; Barachini S; Consoli G; Marazziti D; Polini B; Chiellini G
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542177
[TBL] [Abstract][Full Text] [Related]
24. Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors.
Youssef DA; El-Fayoumi HM; Mahmoud MF
Biomed Pharmacother; 2019 Feb; 110():145-154. PubMed ID: 30469079
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Rossi F; Tortora C; Argenziano M; Di Paola A; Punzo F
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471272
[TBL] [Abstract][Full Text] [Related]
26. (-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.
Alberti TB; Barbosa WL; Vieira JL; Raposo NR; Dutra RC
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368293
[TBL] [Abstract][Full Text] [Related]
27. Protective Effects of (
Scandiffio R; Geddo F; Cottone E; Querio G; Antoniotti S; Gallo MP; Maffei ME; Bovolin P
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114564
[TBL] [Abstract][Full Text] [Related]
28. The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain.
Klauke AL; Racz I; Pradier B; Markert A; Zimmer AM; Gertsch J; Zimmer A
Eur Neuropsychopharmacol; 2014 Apr; 24(4):608-20. PubMed ID: 24210682
[TBL] [Abstract][Full Text] [Related]
29. β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors.
Irrera N; D'Ascola A; Pallio G; Bitto A; Mazzon E; Mannino F; Squadrito V; Arcoraci V; Minutoli L; Campo GM; Avenoso A; Bongiorno EB; Vaccaro M; Squadrito F; Altavilla D
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31370242
[TBL] [Abstract][Full Text] [Related]
30. The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration.
Andrade-Silva M; Correa LB; Candéa AL; Cavalher-Machado SC; Barbosa HS; Rosas EC; Henriques MG
Inflamm Res; 2016 Nov; 65(11):869-879. PubMed ID: 27379721
[TBL] [Abstract][Full Text] [Related]
31. β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
Aly E; Khajah MA; Masocha W
Molecules; 2019 Dec; 25(1):. PubMed ID: 31892132
[TBL] [Abstract][Full Text] [Related]
32. Beta-Caryophyllene, a Plant-Derived CB2 Receptor Agonist, Protects SH-SY5Y Cells from Cadmium-Induced Toxicity.
Mannino F; Pallio G; Imbesi C; Scarfone A; Puzzolo D; Micali A; Freni J; Squadrito F; Bitto A; Minutoli L; Irrera N
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895166
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist.
Hashiesh HM; Sharma C; Goyal SN; Jha NK; Ojha S
Front Pharmacol; 2021; 12():702675. PubMed ID: 34393784
[TBL] [Abstract][Full Text] [Related]
34. β-Caryophyllene Reduces the Inflammatory Phenotype of Periodontal Cells by Targeting CB2 Receptors.
Picciolo G; Pallio G; Altavilla D; Vaccaro M; Oteri G; Irrera N; Squadrito F
Biomedicines; 2020 Jun; 8(6):. PubMed ID: 32560286
[TBL] [Abstract][Full Text] [Related]
35. β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.
Varga ZV; Matyas C; Erdelyi K; Cinar R; Nieri D; Chicca A; Nemeth BT; Paloczi J; Lajtos T; Corey L; Hasko G; Gao B; Kunos G; Gertsch J; Pacher P
Br J Pharmacol; 2018 Jan; 175(2):320-334. PubMed ID: 28107775
[TBL] [Abstract][Full Text] [Related]
36. The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a cannabinoid-receptor-independent mechanism.
Santos NA; Martins NM; Sisti FM; Fernandes LS; Ferreira RS; de Freitas O; Santos AC
Chem Biol Interact; 2017 Jan; 261():86-95. PubMed ID: 27871898
[TBL] [Abstract][Full Text] [Related]
37. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
[TBL] [Abstract][Full Text] [Related]
38. Antinociceptive and chondroprotective effects of prolonged β-caryophyllene treatment in the animal model of osteoarthritis: Focus on tolerance development.
Mlost J; Kac P; Kędziora M; Starowicz K
Neuropharmacology; 2022 Feb; 204():108908. PubMed ID: 34856202
[TBL] [Abstract][Full Text] [Related]
39. β-Caryophyllene Inhibits Oxaliplatin-Induced Peripheral Neuropathy in Mice: Role of Cannabinoid Type 2 Receptors, Oxidative Stress and Neuroinflammation.
Agnes JP; Dos Santos B; das Neves RN; Luciano VMM; Benvenutti L; Goldoni FC; Schran RG; Santin JR; Quintão NLM; Zanotto-Filho A
Antioxidants (Basel); 2023 Oct; 12(10):. PubMed ID: 37891972
[TBL] [Abstract][Full Text] [Related]
40. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice.
Bahi A; Al Mansouri S; Al Memari E; Al Ameri M; Nurulain SM; Ojha S
Physiol Behav; 2014 Aug; 135():119-24. PubMed ID: 24930711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
